bimagrumab tirzepatide clinical trial Eli Lilly's Next-Gen Obesity Therapies: A New Era of Dominance? A Study to Investigate Weight – Bimagrumab: a potential anti-obesity drug
Pay in 4 interest-free payments of $6.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13


























